KRN-5500 Uses, Dosage, Side Effects and more
KRN-5500 is under investigation in clinical trial NCT00002923 (KRN5500 in Treating Patients With Metastatic Solid Tumors).
| Trade Name | KRN-5500 |
| Generic | KRN-5500 |
| Type | |
| Formula | C28H43N7O7 |
| Weight | Average: 589.694 Monoisotopic: 589.322396753 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
